1.
Introduction
1.1)
Company profile
AIN
MEDICARE SDN BHD (AMSB) that was established in 1993 is a trusted name and
leading manufacturer of pharmaceutical products, ranging from Large Volume
Parenterals, Small Volume Parenterals, Irrigation Solutions, Haemodialysis
Concentrates and Peritoneal Dialysis Solutions.
Located
in Kelantan, on the East Coast of Peninsular Malaysia, the company operates
from a multi-million dollar state-of-the-art pharmaceutical complex. The
complex, inaugurated by former Prime Minister Tun Dr. Mahathir Mohamad in 1997,
is fully equipped with production floor, microbiological and chemical
laboratories, warehouse and administrative centre.
Picture 1: Tun Dr
Mahathir during AMSB opening ceremony
A
wholly-Malaysian owned company, AIN
MEDICARE SDN BHD is helmed by the Chairman, Dato' Wan Ariff
Bin Wan Hamzah and Chief Executive Officer, Dr. Syed Ibrahim Bin Mohd. Ismail.
Over the years, this far-sighted leadership and strategic management system has
successfully steered the company towards numerous remarkable achievements.
Today, AIN
MEDICARE SDN BHD's authorized share capital stood at RM 20 million with paid up
share capital of RM 20 million.
AIN
MEDICARE SDN BHD's
products have gained international acceptance and are used by private and
public health care sectors as well as non-profit healthcare providers in
Malaysia and abroad benefiting millions of people across the globe.
1.2) Company Vision
To
further innovate superior quality healthcare products to the highest standard
and to provide outstanding customer services worldwide.
1.3) Company Mission
AMSB is committed to provide reliable and quality products
and services that consistently meet the satisfaction of health professionals and
patients, in compliance with regulatory requirements and best practices.
2. Nature
Of CSR Work Done So Fars
With more than 700 work forces, AIN
MEDICARE SDN BHD
has produced a range of intravenous solution products, both Large Volume
Parentals (LVP) as well as Small Volume Parentals (SVP). Intravenous (IV) solution
is a medical solution that administrated directly into human blood vein by using
syringe instead of normal human digestion system. Since it is directly injected
into human blood vein, the IV solution need to be processed properly to avoid
blood contamination which will lead to death. Among IV solution that produced
by AMSB are:
I.
Sodium Chloride
II.
Dextrose
III.
Mannitol
IV.
Potassium Chloride
Picture 2: AMSB’s IV
solution products
Besides,
AIN
MEDICARE SDN BHD also produced Haemodialysis
concentrates and Peritoneal dialysis solutions. H
aemodialysis is a method that is used to achieve the
extracorporeal removal of waste products such as
creatinine
and
urea and free
water from the human
blood
when the
kidneys
are in a state of
renal failure. On the other hand,
Peritoneal dialysis is a treatment for
patients with severe chronic
kidney
disease.
Other than that, by modern and
sophisticated technologies such as Blow-Fill and Seal (BFS) machine enables AIN
MEDICARE SDN BHD to increase its production capacity to more than 20 million bottles of IV
solutions annually. BFS machine is an automatic machine that used to produce IV
solution product in plastic bottle.
3. Social/Environment
Impacts Of Their Work
AIN
MEDICARE SDN BHD is known as ‘the king’ of intravenous solution manufacturer in Malaysia. They supplied the IV
solution products to the both government hospitals as well as private hospital
in Malaysia. Moreover, AIN
MEDICARE SDN BHD also is a supplier for IV solution product for more
than 10 countries such as Thailand, Brunei, Philippines, and Sri Lanka.
Picture 3: AMSB product at hospital
4. Future
Plans Of The Company On CRS
Having carved a niche for itself in Malaysia and the
region, AIN
MEDICARE SDN BHD aims to be a market leader in the international healthcare scene.
In order to achieve that, AIN
MEDICARE SDN BHD currently are investing more RM 20 million to
set up new IV solution’s production line. The investment includes sophisticated
machine, building and facilities.
Picture 4:
AMSB’s new machine from Germany under testing
5. Other Relevant Information.
It is not easy to set up a pharmaceutical company since it needs
to be certified by regulatory and will have annually inspection. Any
pharmaceutical company that doesn’t comply with regulatory, it may end up with
license termination. In Malaysia, National Pharmaceutical Control Bureau (NPCB)
under Ministry of Health is responsible for pharceutical company certification.
AMSB had been certified to current Good Manufacturing Practice (cGMP) by NPCB
since 1994.
Other than that,
AIN
MEDICARE SDN BHD has received other
certification from international and local certification organizations such as:
- Certification of Quality
Management System to ISO 9001:2008 by Det Norske Veritas (DNV).
- Certification of Environmental Management System to ISO 14001:2004
by Det Norske Veritas (DNV).
- MS ISO/IEC 17025 Certification for Chemical and Microbiological laboratories
by the Department of Standards Malaysia.
Source: Compilation from various sources